Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice

Fig. 5

Effects of rivaroxaban on human EPC senescence in vitro. To determine the onset of cellular aging, acid β-galactosidase was used as a biochemical marker for acidification (typical for EPC senescence). Data are the mean ± SEM. (*P < 0.05 compared with control, # P < 0.05 compared with HG group, n = 4 for each experiment)

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840